Invention Grant
- Patent Title: HCV protease inhibitors
- Patent Title (中): HCV蛋白酶抑制剂
-
Application No.: US14236468Application Date: 2012-07-23
-
Publication No.: US08969373B2Publication Date: 2015-03-03
- Inventor: Suoming Zhang
- Applicant: Suoming Zhang
- Applicant Address: CN Shanghai
- Assignee: Shanghai Tangrun Pharmaceuticals Co., Ltd.
- Current Assignee: Shanghai Tangrun Pharmaceuticals Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: Wang Law Firm, Inc.
- Agent Li K. Wang; Stephen Hsu
- Priority: CN201110220053 20110802
- International Application: PCT/CN2012/078990 WO 20120723
- International Announcement: WO2013/017026 WO 20130207
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07D495/04 ; C07D207/16 ; A61K31/4355 ; A61K31/4365 ; A61K31/437 ; C07K5/08 ; C07K5/083

Abstract:
A compound of general formula (I); A is O, S, CH, NH or NR′, when O links with Z3, Z1 is N or CRZ1, Z2 is CRZ2, when Z1 links with O, Z2 is CH, Z3 is C—Ar; Ra, Rb, Rc and Rd independently is H, OH, halogen or —Y1—Rm; A1 is NH or CH2; R1′ is alkyl, aryl, cycloalkyl, heterocycloalkyl or heteroaryl; A2 is N, O or linking bond; R1 is hydrogen, or, R1 linking covalently with R3 forms C5-C9 saturated or unsaturated hydrocarbon chain substituted by O or N; R3 is alkyl, cycloalkyl, heterocycloalkyl, alkyl substituted by cycloalkyl etc; R4 is alkoxy-CO, alkyl-NHCO, (alkyl)2NCO, or formyl substituted by aryl, cycloalkyl, heterocycloalkyl.
Public/Granted literature
- US20140163219A1 HCV Protease Inhibitors Public/Granted day:2014-06-12
Information query